Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-014628

EVP, CFO & Treasurer sold 2,398 shares at $10.24 ($24,550)

  • EVP, CFO & Treasurer acquired 88,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Mason Michael EVP, CFO & Treasurer 2022-02-28 Grant or award +88,200 141,508 D
Mason Michael EVP, CFO & Treasurer 2022-02-28 Sale −2,398 $10.24 $24,550 139,110 D
Derivatives
Mason Michael EVP, CFO & Treasurer 2022-02-28 Grant or award · Stock Option (right to buy) +111,600 111,600 D
Open-market sales · 2,398 sh · avg $10.24 · $24,550
Loading xslF345X03/doc4.xml…